Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05426200 · ClinicalTrials.gov registry record · NA
Pre-transplant Health Coaching to Improve Patient-Reported Outcomes in Lung Transplant Candidates
A NA study of Lung Transplant, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 230
- Enrollment target
- 3
- Study locations
NCT05426200: Recruiting NA study of Lung Transplant, sponsored by Mayo Clinic.
NCT05426200 is a NA study of Lung Transplant that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 230 participants, below the 1,261-participant average among 15 other Lung Transplant trials with a reported enrollment target (82% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05426200, a NA study of Lung Transplant, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 230 participants
- Enrollment target
- 3
- Study locations
Study Summary
To examine the effectiveness of an individual health coaching intervention for lung transplant candidates. This intervention will include up to 12 health coaching sessions via phone call over a 12-16 week period. This will be compared to a usual care group the receives pre-transplant care and education alone.
Primary Outcome
Participants will complete questions comprising the CRQ Mastery subdomain (7,10,13, and 19) of a 20-item Chronic Respiratory Questionnaire (CRQ) at baseline and after the 12-week intervention. CRQ Mastery subscores measure self-management abilities and range from 1 to 7, with higher scores indicating higher self-efficacy. The minimum clinically important difference is 0.5.
Conditions Studied
Interventions
- BEHAVIORAL Health Coaching
Study Locations (3)
Florida
- Mayo Clinic - Jacksonville
Minnesota
- Mayo Clinic - Rochester
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2023-01-25 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT05426200 shows while recruiting
NCT05426200 is an interventional study that assigns participants to a tested intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, below the 1,261-participant average among 15 other Lung Transplant trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Lung Transplant appearing as the primary indexed condition, and to 1 intervention - of which Health Coaching is the first listed.
NCT05426200 reports a single indexed study location in Florida, Minnesota, Washington.
Frequently Asked Questions
What is clinical trial NCT05426200 about?
NCT05426200 is a clinical study titled "Pre-transplant Health Coaching to Improve Patient-Reported Outcomes in Lung Transplant Candidates". To examine the effectiveness of an individual health coaching intervention for lung transplant candidates. This intervention will include up to 12 health coaching sessions via phone call over a 12-16 week period. This will be compared to a usual care group the receives pre-transplant care and educat...
What is the current status of trial NCT05426200?
This trial is currently recruiting. It is a NA study. The enrollment target is 230 participants. The study started on 2023-01-25. Estimated completion is 2027-01.
What conditions does trial NCT05426200 study?
This clinical trial studies the following conditions: Lung Transplant.
What interventions are being tested in trial NCT05426200?
The interventions under investigation include: Health Coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT05426200?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05426200 being conducted?
This trial has 3 study locations across Florida, Minnesota, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05426200's enrollment target sits among peer trials
230 7th of 15 higher than 9 of 15 other Lung Transplant trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Transplant trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Planned Semi-Elective Lung Tx Study
RECRUITING · NA
-
A Study of Latin Dance for Post- Lung Transplant
RECRUITING · NA
-
The Effect of the Reflux Band™ Upper Esophageal Sphincter (UES) Assist Device on Reflux for Lung Transplant Recipients
RECRUITING · NA
-
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
RECRUITING · NA
-
TEE and Dysphagia in Lung Transplantation
RECRUITING · NA
-
Progressive Rehabilitation Therapy in Patients With Advanced Lung Disease
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI